Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019272 220013857 0 null Palliative (P) 2015-07-10 2015-07-10 Hydroxycarbamide N null 220026839 HYDROXYCARBAMIDE
220019273 220013857 1.03 null null 2016-05-26 2016-05-26 Hydroxycarbamide N null 220026839 HYDROXYCARBAMIDE
220019275 220007009 null null Palliative (P) 2017-10-26 2017-11-12 AML Interim Guidelines 02 N 220026878 NOT MATCHED
220019277 220007017 1.83 68.1 Disease modification (D) 2016-12-04 2016-12-05 Hydroxycarbamide N N 220026891 HYDROXYCARBAMIDE
220019278 220007020 1.78 68 null null 2016-09-29 Cytarabine Low Dose N N 220026895 CYTARABINE
220019279 220007024 1.04 12.4 Curative (C) null 2016-04-10 null Y null 220026923 NOT MATCHED
220019280 220007026 -1 107.5 Curative (C) 2017-01-17 2017-01-18 Hydroxycarbamide N N 220026928 HYDROXYCARBAMIDE
220019281 220007029 null null Curative (C) 2017-01-28 2017-04-05 null N null 220026950 NOT MATCHED
220019282 220007035 null 62.7 Palliative (P) null 2017-02-12 Hydroxycarbamide 2 N 220026961 HYDROXYCARBAMIDE
220019283 220007040 1.57 null Palliative (P) 2016-01-06 2016-01-13 Cytarabine Low Dose N N 220026962 CYTARABINE
220019285 220007044 1.8 79 Disease modification (D) 2018-08-20 2018-08-20 CYTARABINE null null 220026968 CYTARABINE
220019287 220007053 1.75 76.1 Curative (C) 2016-09-23 2016-11-10 AML MyeChild 01 FLA N N 220026988 NOT MATCHED
220019288 220007055 1.74 9.3 Curative (C) 2014-12-12 2015-01-23 CYTARABINE + FLUDARABINE + MITOXANTRONE N N 220027014 NOT MATCHED
220019289 220007059 null 72.45 Curative (C) 2019-02-18 2019-02-18 CYTARABINE null null 220027025 CYTARABINE
220019290 220007064 1.57 59 Disease modification (D) 2017-12-31 2018-01-25 ATG + Cyclophosphamide TBI Allo N null 220027042 NOT MATCHED
220019291 220007067 null 84.9 null 2017-05-04 2017-05-23 Rituximab N N 220027042 RITUXIMAB
220019292 220007068 0 65.7 Disease modification (D) 2014-05-29 2015-03-14 Dasatinib N N 220027059 DASATINIB
220019294 220019621 1.49 73.6 null 2016-10-26 2016-10-26 Rituximab N N 220027115 RITUXIMAB
220019295 220007076 null 76.6 Curative (C) 2017-04-13 2017-04-18 Alemtuz+Fludara+Melphalan RIC MUD null null 220027129 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019296 220007077 0 98.9 Curative (C) 2017-12-28 2018-03-16 AML 18 TRIAL 1 N 220027135 AML18 TRIAL
220019297 220013901 null 55 Disease modification (D) null 2016-09-11 AML 18 TRIAL 1 N 220027145 AML18 TRIAL
220019298 220007086 1.58 72 Curative (C) 2016-04-10 2016-06-19 AML18 PILOT TRIAL null N 220027170 PILOT TRIAL
220019299 220007088 1.72 69.4 Curative (C) 2016-09-11 2016-11-03 AML18 PILOT TRIAL N N 220027179 PILOT TRIAL
220019300 220013909 0 76.5 Curative (C) 2014-01-12 2014-03-25 AML 18 TRIAL N N 220027205 AML18 TRIAL
220019301 220007098 1.82 0 Disease modification (D) 2016-04-27 2016-04-27 Dasatinib 02 N 220027219 DASATINIB
220019302 220007099 1.77 87.5 Curative (C) null 2017-08-03 AML18 PILOT TRIAL Y null 220027227 PILOT TRIAL
220019303 220007100 1.77 119 Curative (C) 2017-06-17 2017-06-26 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220027231 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019304 220007102 1.95 72.6 Not known (9) 2016-10-07 2016-10-11 Dasatinib null N 220027237 DASATINIB
220019305 220007104 1.6 44.3 Palliative (P) null 2013-06-26 AML 18 TRIAL 1 N 220027247 AML18 TRIAL
220019306 220007113 1.82 null Curative (C) 2016-08-22 2016-08-23 Rituximab N null 220027295 RITUXIMAB
220019307 220007117 1.6 0 Curative (C) 2018-03-15 2018-09-29 Dasatinib N N 220027304 DASATINIB
220019308 220007119 null 40.3 Curative (C) 2015-01-13 2015-01-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220027307 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019309 220007120 1.82 99.7 Curative (C) 2014-06-07 2014-12-27 Dasatinib N N 220027314 DASATINIB
220019310 220013927 1.67 55.5 Adjuvant (A) 2013-11-04 2013-11-04 Dasatinib N N 220027337 DASATINIB
220019311 220007128 null 66.6 Curative (C) 2015-06-04 2015-06-21 ALEMTUZUMAB + FLUDARABINE + MELPHALAN null null 220027359 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019312 220007129 1.7 121 Curative (C) 2013-11-30 2013-11-30 Dasatinib 02 N 220027366 DASATINIB
220019313 220007132 1.95 null Palliative (P) 2018-03-23 2018-03-23 Dasatinib 2 N 220027371 DASATINIB
220019314 220007137 null null null 2014-08-16 2015-02-01 Dasatinib null N 220027403 DASATINIB
220019315 220007140 1.71 null Neo-adjuvant (N) 2017-07-02 2017-07-02 Dasatinib 2 N 220027407 DASATINIB
220019316 220013936 null 0 Curative (C) 2015-06-21 2017-08-10 Dasatinib 2 N 220027430 DASATINIB
220019317 220007145 null 0 Curative (C) 2015-08-27 2015-08-27 Dasatinib 02 N 220027439 DASATINIB
220019318 220019636 1.67 84.1 Curative (C) 2016-08-25 2016-09-07 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220027456 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019319 220007152 1.64 66.6 Curative (C) 2016-09-28 2016-10-09 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220027472 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220019320 220007157 null 78.6 Curative (C) 2015-03-19 2015-03-19 Dasatinib 02 N 220027479 DASATINIB
220019321 220007159 0 null Disease modification (D) 2016-05-16 2016-05-21 Dasatinib N N 220027491 DASATINIB
220019322 220017590 1.55 67.2 Curative (C) 2016-08-13 2016-08-18 AML18 PILOT TRIAL N null 220027491 PILOT TRIAL
220019323 220007160 null 0 Curative (C) 2015-07-25 2015-07-27 AML 18 TRIAL N null 220027501 AML18 TRIAL
220019324 220019640 null 56 Curative (C) 2015-01-09 2015-07-31 Dasatinib N N 220027506 DASATINIB
220019325 220007163 1.83 95.2 Curative (C) 2013-10-26 2013-10-27 AML18 PILOT TRIAL N N 220027516 PILOT TRIAL
220019326 220007164 1.7 111.5 Adjuvant (A) 2017-04-28 2017-05-02 Dasatinib 02 N 220027518 DASATINIB